Evolent Health, Inc.
EVH
$4.13
-$0.03-0.72%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -496.52M | -534.51M | -128.18M | -130.45M | -108.96M |
| Total Depreciation and Amortization | 90.65M | 92.65M | 54.71M | 60.10M | 65.73M |
| Total Amortization of Deferred Charges | 38.79M | 37.80M | 36.36M | 33.69M | 34.25M |
| Total Other Non-Cash Items | 446.25M | 500.29M | 140.05M | 138.02M | 128.67M |
| Change in Net Operating Assets | -45.87M | -57.38M | -139.13M | -134.68M | -101.26M |
| Cash from Operations | 33.29M | 38.84M | -36.19M | -33.33M | 18.42M |
| Capital Expenditure | -27.40M | -34.09M | -79.80M | -88.13M | -39.48M |
| Sale of Property, Plant, and Equipment | 91.31M | 91.31M | -- | -- | -- |
| Cash Acquisitions | -57.44M | -57.44M | -19.50M | -19.50M | -19.50M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.00K | -14.00K | -3.02M | -5.65M | -7.31M |
| Cash from Investing | 6.45M | -233.00K | -102.32M | -113.28M | -66.29M |
| Total Debt Issued | 187.05M | 408.05M | 448.32M | 279.58M | 279.58M |
| Total Debt Repaid | -280.48M | -342.98M | -228.73M | -61.97M | -61.97M |
| Issuance of Common Stock | -- | -- | -- | 2.34M | 2.40M |
| Repurchase of Common Stock | -42.45M | -45.22M | -45.47M | -5.62M | -5.96M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.55M | -11.13M | -15.93M | -19.14M | -19.58M |
| Other Financing Activities | -5.32M | -44.64M | -4.13M | -8.33M | -102.06M |
| Cash from Financing | -147.75M | -35.92M | 154.05M | 186.86M | 92.41M |
| Foreign Exchange rate Adjustments | -1.10M | -486.00K | -397.00K | -227.00K | -168.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.10M | 2.20M | 15.15M | 40.02M | 44.37M |